Evidence map›Paper›PMID 31975838›Full record

ReviewFocus (American Psychiatric Publishing)2017

Overlay of Late-Life Depression and Cognitive Impairment.

Rehan Aziz, David Steffens

Open access · greenAbstract readReview
In one paragraph

Review in Focus (American Psychiatric Publishing), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pathomechanisms of Vascular Depression in Older Adults.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Updates in Geriatric Psychiatry.Focus (American Psychiatric Publishing) · 2021
    Article
  18. Cognitive effects of vortioxetine in older adults: a systematic review.Therapeutic advances in psychopharmacology · 2021
    Review
  19. Neurocognitive Disorders in Geriatric Psychiatry.Focus (American Psychiatric Publishing) · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rehan AzizDr. Aziz is associate professor of psychiatry with the Departments of Psychiatry and Neurology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey (email: (raziz@rwjms.rutgers.edu). Dr. Steffens is professor and chairman of psychiatry, Department of Psychiatry, University of Connecticut Health Center, Farmington.
David SteffensDr. Aziz is associate professor of psychiatry with the Departments of Psychiatry and Neurology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey (email: (raziz@rwjms.rutgers.edu). Dr. Steffens is professor and chairman of psychiatry, Department of Psychiatry, University of Connecticut Health Center, Farmington.
Johnson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article appraises several facets of the linkage between depression and cognitive impairment, including dementia, mild cognitive impairment, and vascular dementia. Potential mechanisms for this association are examined. This review was crafted to be extensive but not exhaustive. The authors searched PubMed, using the terms

Indexed as

Cognitive DisordersDepression

Identifiers

PMID31975838
PMCPMC6519628
OpenAlexW2579183882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.